Abstract
The response of rosacea-associated erythema and telangiectasia to treatment with the pulsed tunable dye laser (PDL) was evaluated in 12 patients. Improvements in erythema, telangiectasia, flushing, the physician's and the patient's perception of overall severity, treatment tolerability, and the adverse side effects were examined. With the sole exception of the patient's assessment of overall severity we have found highly significant improvements in all other parameters evaluated, with excellent tolerance of treatment. We therefore conclude that the PDL is a safe and effective treatment for the erythemato-telangiectatic component of rosacea.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Paper received 13 March 2001; accepted after revision 26 June 2001.
Rights and permissions
About this article
Cite this article
Clark, S., Lanigan, S. & Marks, R. Laser Treatment of Erythema and Telangiectasia Associated with Rosacea. Lasers Med Sci 17, 26–33 (2002). https://doi.org/10.1007/s10103-002-8263-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10103-002-8263-8